Paul Andrew Moore
Known title: Chief Scientific OfficerCIK: 0001938192
Associated companies
Transaction History
| ZYME | ▲ Buy | Option Exercise | 17,666 | $0 | 1/12/2026 | View on chart |
| ZYME | ▼ Sell | Open Market | 9,560 | $217K | 1/12/2026 | View on chart |
| ZYME | ▲ Buy | Option Exercise | 17,168 | $0 | 1/5/2026 | View on chart |
| ZYME | ▼ Sell | Open Market | 9,289 | $233K | 1/5/2026 | View on chart |
| ZYME | ▲ Buy | Option Exercise | 20,000 | $0 | 1/5/2026 | View on chart |
| ZYME | ▼ Sell | Open Market | 10,821 | $272K | 1/5/2026 | View on chart |
| ZYME | ▲ Buy | Option Exercise | 17,166 | $0 | 1/6/2025 | View on chart |
| ZYME | ▼ Sell | Open Market | 9,792 | $146K | 1/6/2025 | View on chart |
| ZYME | ▲ Buy | Option Exercise | 20,000 | $0 | 1/6/2025 | View on chart |
| ZYME | ▼ Sell | Open Market | 11,408 | $170K | 1/6/2025 | View on chart |
| ZYME | ▼ Sell | Open Market | 2,339 | $26K | 1/8/2024 | View on chart |
| ZYME | ▲ Buy | Option Exercise | 17,166 | $0 | 1/5/2024 | View on chart |
| ZYME | ▼ Sell | Open Market | 7,460 | $79K | 1/5/2024 | View on chart |